Ultragenyx Pharmaceutical Inc.
USD28.62
+0.09 (+0.32%)
CEO
Emil D. Kakkis
IPO Date
2014-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$29.00
Prev. Close
$28.53
Day Low
$28.23
Day High
$29.10
52W Low
$18.29
52W High
$39.89
Market Cap
$2.82B
Volume
2.22M
| 2,000 |
| $25.05 |
| 15 Jun 2026 | Parschauer Karah Herdman | EVP and Chief Legal Officer | S-Sale | Disposed | 1,899 | $24.62 |
| 1 Jun 2026 | Horn Howard | Chief Financial Officer | S-Sale | Disposed | 4,653 | $23.77 |
| 18 May 2026 | Fust Matthew K | director | A-Award | Acquired | 7,751 | $0.00 |
| 18 May 2026 | Fust Matthew K | director | A-Award | Acquired | 14,058 | $25.80 |
| 18 May 2026 | SULIMAN SHEHNAAZ | director | A-Award | Acquired | 7,751 | $0.00 |
| 18 May 2026 | SULIMAN SHEHNAAZ | director | S-Sale | Disposed | 5,740 | $25.12 |
| 18 May 2026 | SULIMAN SHEHNAAZ | director | A-Award | Acquired | 14,058 | $25.80 |
| 18 May 2026 | Ray Amrit | director | A-Award | Acquired | 7,751 | $0.00 |
| $1,001 - $15,000 |
| 12 Sept 2025 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 15 Aug 2025 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 8 Feb 2022 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 8 Feb 2022 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 8 Sept 2021 | Kurt Schrader | Kurt Schrader | Purchase | $1,001 - $15,000 |